These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 19932151)

  • 1. Ligand internalization and recycling by human recombinant somatostatin type 4 (h sst(4)) receptors expressed in CHO-K1 cells.
    Smalley KS; Koenig JA; Feniuk W; Humphrey PP
    Br J Pharmacol; 2001 Mar; 132(5):1102-10. PubMed ID: 11226141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review.
    Kasprzak A; Geltz A
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin-SSTR3-GSK3 modulates human T-cell responses by inhibiting OXPHOS.
    Zhang B; Feng H; Lin H; Li R
    Front Immunol; 2024; 15():1322670. PubMed ID: 38426092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Bruyne E, Bos TJ, Schuit F, et al. IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms. Blood. 2010;115(12):2430-2440.
    Blood; 2023 Sep; 142(11):1027. PubMed ID: 37707871
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies.
    Werner C; Dirsch O; Dahmen U; Grimm MO; Schulz S; Lupp A
    Transl Oncol; 2020 Sep; 13(9):100801. PubMed ID: 32460182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal Changes of Somatostatin Expression in Hippocampi of C57BL/6 Mice; Modulation of Neuroblast Differentiation in the Hippocampus.
    Yoo DY; Kim W; Jung HY; Hwang IK
    Vet Sci; 2023 Jan; 10(2):. PubMed ID: 36851385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST
    Amarù J; Barbieri F; Arvigo M; Solari A; Bajetto A; Nista F; Campana C; Gaggero G; Prior A; Criminelli Rossi D; Zona G; Ferone D; Florio T; Gatto F
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms.
    Gatto F; Barbieri F; Arvigo M; Thellung S; Amarù J; Albertelli M; Ferone D; Florio T
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.
    Günther T; Tulipano G; Dournaud P; Bousquet C; Csaba Z; Kreienkamp HJ; Lupp A; Korbonits M; Castaño JP; Wester HJ; Culler M; Melmed S; Schulz S
    Pharmacol Rev; 2018 Oct; 70(4):763-835. PubMed ID: 30232095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.
    Briest F; Grabowski P
    Theranostics; 2014; 4(4):336-65. PubMed ID: 24578720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle.
    Berruti A; Vignani F; Russo L; Bertaglia V; Tullio M; Tucci M; Poggio M; Dogliotti L
    Open Access J Urol; 2010 Jul; 2():109-24. PubMed ID: 24198620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian Society of Endocrinology Career Award Lecture: from somatostatin to…somatomedin.
    Ferone D
    J Endocrinol Invest; 2012 Oct; 35(9):869-74. PubMed ID: 22932163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth.
    Ruscica M; Magni P; Steffani L; Gatto F; Albertelli M; Rametta R; Valenti L; Ameri P; Magnaghi V; Culler MD; Minuto F; Ferone D; Arvigo M
    Mol Cell Endocrinol; 2014 Feb; 382(2):860-70. PubMed ID: 24211300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
    Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.
    Ferone D; Arvigo M; Semino C; Jaquet P; Saveanu A; Taylor JE; Moreau JP; Culler MD; Albertelli M; Minuto F; Barreca A
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1044-50. PubMed ID: 16046458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin, somatostatin analogs and somatostatin receptor dynamics in the biology of cancer progression.
    Ruscica M; Arvigo M; Steffani L; Ferone D; Magni P
    Curr Mol Med; 2013 May; 13(4):555-71. PubMed ID: 22934849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analogs and radiopeptides in cancer therapy.
    Froidevaux S; Eberle AN
    Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of prostate cancer cell proliferation by somatostatin receptor activation.
    Ruscica M; Arvigo M; Gatto F; Dozio E; Feltrin D; Culler MD; Minuto F; Motta M; Ferone D; Magni P
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):254-62. PubMed ID: 19932151
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.